Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
CNY 2.91
(-9.63%)
CNY 2.91
(-9.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 76.31 Million CNY | 216.85% |
| 2022 | 25.44 Million CNY | 128.89% |
| 2021 | -121.63 Million CNY | -347.19% |
| 2020 | 147.85 Million CNY | 98.34% |
| 2019 | -1.77 Billion CNY | -583.66% |
| 2018 | 308.19 Million CNY | 18.17% |
| 2017 | 285.58 Million CNY | 10.84% |
| 2016 | 172.91 Million CNY | 86.76% |
| 2015 | 99.73 Million CNY | 28.46% |
| 2014 | 73.39 Million CNY | 132.66% |
| 2013 | 30.99 Million CNY | 744.52% |
| 2012 | -8.16 Million CNY | -107.15% |
| 2011 | 71.88 Million CNY | 3.45% |
| 2010 | 69.35 Million CNY | -11.8% |
| 2009 | 78.91 Million CNY | 16.14% |
| 2008 | 68.13 Million CNY | 20.59% |
| 2007 | 62.96 Million CNY | 79.65% |
| 2006 | 34.54 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 44.09 Thousand CNY | -99.57% |
| 2024 Q1 | 7.58 Million CNY | 145.69% |
| 2024 Q2 | 10.21 Million CNY | -33.31% |
| 2023 Q4 | -790.12 Thousand CNY | 91.74% |
| 2023 Q2 | 41.51 Million CNY | 286.06% |
| 2023 FY | - CNY | 216.85% |
| 2023 Q1 | 10.75 Million CNY | 124.4% |
| 2023 Q3 | -9.57 Million CNY | -123.05% |
| 2022 Q1 | -8.67 Million CNY | 86.56% |
| 2022 Q3 | -10.1 Million CNY | -362.44% |
| 2022 Q2 | -2.18 Million CNY | 74.82% |
| 2022 FY | - CNY | 128.89% |
| 2022 Q4 | 4.79 Million CNY | 147.44% |
| 2021 Q1 | -18.56 Million CNY | -475.19% |
| 2021 Q4 | -64.56 Million CNY | -164.08% |
| 2021 FY | - CNY | -347.19% |
| 2021 Q3 | -24.44 Million CNY | -0.78% |
| 2021 Q2 | -24.26 Million CNY | -30.66% |
| 2020 Q2 | -23.84 Million CNY | -217.28% |
| 2020 FY | - CNY | 98.34% |
| 2020 Q4 | -3.22 Million CNY | 90.62% |
| 2020 Q1 | -7.51 Million CNY | 99.43% |
| 2020 Q3 | -34.4 Million CNY | -44.31% |
| 2019 FY | - CNY | -583.66% |
| 2019 Q4 | -1.3 Billion CNY | -7207.12% |
| 2019 Q1 | 82.77 Million CNY | 447.29% |
| 2019 Q3 | -17.89 Million CNY | -939.14% |
| 2019 Q2 | 2.13 Million CNY | -97.42% |
| 2018 FY | - CNY | 18.17% |
| 2018 Q3 | 51.71 Million CNY | -41.37% |
| 2018 Q4 | -23.83 Million CNY | -146.09% |
| 2018 Q2 | 88.21 Million CNY | 2.58% |
| 2018 Q1 | 85.99 Million CNY | 4384.88% |
| 2017 Q4 | -2 Million CNY | -103.37% |
| 2017 Q3 | 59.62 Million CNY | -10.52% |
| 2017 Q2 | 66.63 Million CNY | 22.02% |
| 2017 Q1 | 54.61 Million CNY | 117.69% |
| 2017 FY | - CNY | 10.84% |
| 2016 Q1 | 43.76 Million CNY | 96.44% |
| 2016 Q4 | 25.08 Million CNY | -13.13% |
| 2016 Q3 | 28.87 Million CNY | -42.77% |
| 2016 FY | - CNY | 86.76% |
| 2016 Q2 | 50.45 Million CNY | 15.28% |
| 2015 Q3 | 12.54 Million CNY | -37.41% |
| 2015 Q2 | 20.04 Million CNY | 13.29% |
| 2015 Q1 | 17.69 Million CNY | -32.4% |
| 2015 Q4 | 22.28 Million CNY | 77.56% |
| 2015 FY | - CNY | 28.46% |
| 2014 Q3 | 6.2 Million CNY | -58.27% |
| 2014 Q2 | 14.86 Million CNY | 27.98% |
| 2014 Q1 | 11.61 Million CNY | -44.44% |
| 2014 FY | - CNY | 132.66% |
| 2014 Q4 | 26.17 Million CNY | 322.09% |
| 2013 Q1 | -7.45 Million CNY | 14.52% |
| 2013 FY | - CNY | 744.52% |
| 2013 Q3 | 2.36 Million CNY | 277.11% |
| 2013 Q4 | 20.9 Million CNY | 782.32% |
| 2013 Q2 | -1.33 Million CNY | 82.06% |
| 2012 Q3 | -7.83 Million CNY | 34.68% |
| 2012 Q1 | 3.54 Million CNY | -76.05% |
| 2012 Q2 | -11.98 Million CNY | -437.83% |
| 2012 Q4 | -8.72 Million CNY | -11.4% |
| 2012 FY | - CNY | -107.15% |
| 2011 FY | - CNY | 3.45% |
| 2011 Q1 | 18.3 Million CNY | 36.37% |
| 2011 Q2 | 14.81 Million CNY | -19.05% |
| 2011 Q3 | 11.92 Million CNY | -19.51% |
| 2011 Q4 | 14.81 Million CNY | 24.23% |
| 2010 Q2 | 6.84 Million CNY | -66.2% |
| 2010 Q3 | 13.33 Million CNY | 94.97% |
| 2010 Q4 | 13.42 Million CNY | 0.64% |
| 2010 FY | - CNY | -11.8% |
| 2010 Q1 | 20.23 Million CNY | 24.15% |
| 2009 Q3 | 15.21 Million CNY | -3.55% |
| 2009 Q1 | 18.52 Million CNY | 0.0% |
| 2009 FY | - CNY | 16.14% |
| 2009 Q4 | 16.3 Million CNY | 7.18% |
| 2009 Q2 | 15.76 Million CNY | -14.86% |
| 2008 FY | - CNY | 20.59% |
| 2007 FY | - CNY | 79.65% |
| 2006 FY | - CNY | 0.0% |